Neovascular Glaucoma
Ophthalmology
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
BayerAflibercept
Clinical Trials (1)
Total enrollment: 480 patients across 1 trials
Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
Start: Nov 2020Est. completion: Jun 2028480 patients
N/ARecruiting
Related Jobs in Ophthalmology
Lead Data Manager
Genomics
Remote
8h ago
Cleanroom and Laboratory Technician
SAB BIO
8h ago
APAC Regulatory Affairs Manager
Johnson & Johnson
Singapore, Singapore
Yesterday
Clinical Operations Manager
Johnson & Johnson
Irvine, California, United States of America
Yesterday
$117K - $201K/yr
Site Delivery Leader MLL
Johnson & Johnson
Gent, East Flanders, Belgium
Yesterday
BM 喀什 PSR HY
Johnson & Johnson
Urumqi, Xinjiang, China
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 480 patients
1 companies competing in this space